Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use

Four-factor prothrombin complex concentrate (4F-PCC) may be an option for patients with bleeding unrelated to therapeutic anticoagulation to help with bleeding cessation and reduce blood component requirements.

Source: Transfusion and Apheresis Science - July 5, 2023 Category: Hematology Authors: Elizabeth Uttaro, Mikaela R. Young, Jennifer Falvey, Jenna M. Corvelli, Nicole M. Acquisto Source Type: research